Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025
임상 차세대 시퀀싱(NGS) 데이터 분석 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년에는 CAGR 20.5%로 성장할 전망이며, 87억 3,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 리퀴드 바이옵시 기술의 채용 증가, 데이터 분석에서 인공지능의 통합, 정밀의료 구상의 확대, 신규 시퀀싱 기술의 출현, 집단 유전체노믹스 구상에 대한 주목의 고조에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향에는 동반 진단 성장, 분산형 검사 모델 대두, 클라우드 기반 솔루션 이용 증가, 비침습적 산전 검사에서 NGS 용도 확대, 데이터 해석을 위한 표준화 프로토콜 개발 등이 포함됩니다.
임상 차세대 시퀀싱(NGS) 데이터 분석 시장은 맞춤형 의료에 대한 수요 증가에 힘입어 성장할 것으로 예상됩니다. 개인의 유전적, 환경적, 라이프스타일적 요인에 맞춘 개별화 의료는 게놈 기술, 질병의 복잡화, 치료 성적의 향상, 헬스케어 비용의 급등에 의해 주목받고 있습니다. 차세대 시퀀싱(NGS) 데이터 분석은 개별화 의료에서 매우 중요한 역할을 하며, 여러 유전자의 신속하고 정확한 시퀀싱을 용이하게 함으로써 개인의 유전자 프로파일에 대한 이해를 높입니다. 예를 들어 2022년 10월 데이터에서는 상당수의 유전자 검사 제품 및 개별화 의약품이 보고되었으며, 개별화 의약품이 신약 승인의 주목할 부분을 차지하고 있다는 점에서 개별화 의료의 채택을 추진하는 데 NGS 데이터 해석이 불가결한 역할을 담당하고 있음을 알 수 있습니다.
임상 차세대 시퀀싱(NGS) 데이터 분석 시장의 주요 기업은 유전체 분석의 정확성에 대한 급증하는 요구에 부응하기 위해 기술 혁신을 진행하고 있습니다. NextSeq 2000 시퀀스 시스템과 같은 선진적인 솔루션은 이 영역에서 중요한 개발의 대표입니다. 이 시스템은 DNA 시퀀싱 프로세스를 합리화하도록 설계된 통합 하드웨어 및 소프트웨어 컴포넌트로 구성되어 DNA 분자 내의 정확한 뉴클레오티드 시퀀싱을 제공합니다. 예를 들어 Illumina Inc.가 2022년 9월에 발표한 NovaSeq X 시리즈는 생산 규모의 시퀀스에 패러다임 변화를 가져와 속도, 파워 및 지속 가능성 향상을 자랑합니다. XLEAP-SBS 케미스트리 및 초고밀도 플로우 셀과 같은 혁신적인 기술을 활용한 NovaSeq X 시리즈는 처리량 및 시퀀스 정확도를 대폭 향상시켜 유전체 분석에 대한 높아지는 요구에 부응합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 성장률 분석
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 솔루션 및 서비스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- NGS 데이터 분석 도구
- NGS 데이터 분석 및 시퀀싱 서비스
- NGS 스토리지, 관리, 클라우드 컴퓨팅 플랫폼
- 플랫폼
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 기술별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 시퀀싱 바이 신세시스(SBS)
- 나노포어 시퀀싱
- 단일 분자 실시간(SMRT) 시퀀싱
- 기타 기술
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 진단
- 의약품의 발견 및 설계
- 의학 조사
- 기타 용도
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 병원 및 진료소
- 학술기관 및 연구센터
- 바이오테크놀러지 기업
- 생명 과학 기술 벤더
- 기타 최종 사용자
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : NGS 데이터 분석 도구 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 소프트웨어 플랫폼
- 데이터 분석 툴
- 바이오인포매틱스 툴
- 데이터 분석 솔루션
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : NGS 데이터 분석 및 시퀀싱 서비스 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 시퀀싱 서비스
- 데이터 분석 서비스
- 컨설팅 서비스
- 조사 및 진단 서비스
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : NGS 스토리지, 관리 및 클라우드 컴퓨팅 플랫폼 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 데이터 스토리지 솔루션
- 데이터 관리 플랫폼
- 클라우드 기반 플랫폼
- 클라우드 스토리지 서비스
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 플랫폼별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 시퀀싱 플랫폼
- NGS 계측 플랫폼
- 통합 NGS 플랫폼
제7장 지역별 및 국가별 분석
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 경쟁 구도
- 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 기업 프로파일
- Roche Diagnostics 개요, 제품 및 서비스, 전략 및 재무 분석
- Thermo Fisher Scientific Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Eurofins Scientific 개요, 제품 및 서비스, 전략 및 재무 분석
- Agilent Technologies Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Illumina Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- PerkinElmer Inc.
- Bio-Rad Laboratories Inc.
- Qiagen
- BGI Group
- 10x Genomics
- Genomic Health
- Oxford Nanopore Technologies PLC
- Pacific Biosciences of California Inc.
- Sophia Genetics
- Genewiz
- Partek Inc.
- DNAnexus
- BioNano Genomics
- PierianDx
- GENAPSYS
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 새로운 기회를 제공하는 국가(2029년)
- 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 새로운 기회를 제공하는 부문(2029년)
- 임상 차세대 시퀀싱(NGS) 데이터 분석 시장 : 성장 전략(2029년)
제36장 부록
AJY
Clinical next-generation sequencing (NGS) data analysis is the interpretation of genetic information acquired through advanced sequencing technologies within a clinical context. These technologies enable the rapid and cost-effective sequencing of large DNA or RNA samples, allowing for the identification of genetic variations associated with diseases or conditions. This analytical process is essential for comprehending the genetic underpinnings of diseases, supporting personalized medicine approaches, and guiding clinical decision-making.
The main types of solutions and services in clinical next-generation sequencing (NGS) data analysis encompass NGS data analysis tools, NGS data analysis and sequencing services, and NGS storage, management, and cloud computing platforms. NGS data analysis tools are software applications designed to interpret and process the vast amount of data generated through NGS technologies. Leveraging various sequencing technologies such as sequencing by synthesis (SBS), nanopore sequencing, and single-molecule real-time (SMRT) sequencing, these tools find applications in diagnostics, drug discovery, medical research, and other domains. End-users of these tools span hospitals, clinics, academic institutes, research centers, biotechnology companies, and life science technology vendors.
The clinical next-generation sequencing (NGS) data analysis market research report is one of a series of new reports from The Business Research Company that provides clinical next-generation sequencing (NGS) data analysis market statistics, including clinical next-generation sequencing (NGS) data analysis industry global market size, regional shares, competitors with a clinical next-generation sequencing (NGS) data analysis market share, detailed clinical next-generation sequencing (NGS) data analysis market segments, market trends and opportunities, and any further data you may need to thrive in the clinical next-generation sequencing (NGS) data analysis industry. This clinical next-generation sequencing (NGS) data analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The clinical next-generation sequencing (NGS) data analysis market size has grown exponentially in recent years. It will grow from $3.43 billion in 2024 to $4.15 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to research advancements in genomics, declining sequencing costs, growing demand for personalized medicine, expanding applications in clinical diagnostics, increasing prevalence of genetic diseases.
The clinical next-generation sequencing (NGS) data analysis market size is expected to see exponential growth in the next few years. It will grow to $8.73 billion in 2029 at a compound annual growth rate (CAGR) of 20.5%. The growth in the forecast period can be attributed to rising adoption of liquid biopsy techniques, integration of artificial intelligence in data analysis, expansion of precision medicine initiatives, emergence of novel sequencing technologies, increasing focus on population genomics initiatives. Major trends in the forecast period include growth of companion diagnostics, rise of decentralized testing models, increasing use of cloud-based solutions, expansion of NGS applications in non-invasive prenatal testing, development of standardized protocols for data interpretation.
The clinical next-generation sequencing data analysis market is poised for growth, propelled by the rising demand for personalized medicines. Personalized medicine, tailored to individual genetic, environmental, and lifestyle factors, gains prominence due to genomic technologies, increasing disease complexity, improved treatment outcomes, and escalating healthcare costs. Next-generation sequencing (NGS) data analysis plays a pivotal role in personalized medicine, facilitating rapid and accurate sequencing of multiple genes, thereby enhancing understanding of an individual's genetic profile. For example, data from October 2022 reports a significant number of genetic testing products and personalized medicines, with personalized medicines accounting for a notable portion of new drug approvals, underlining the integral role of NGS data analysis in driving personalized medicine adoption.
Key players in the clinical NGS data analysis market are innovating to meet burgeoning demands for genomic analysis accuracy. Advanced solutions such as the NextSeq 2000 Sequencing System represent significant developments in this realm. This system comprises integrated hardware and software components designed to streamline DNA sequencing processes, offering precise nucleotide sequencing within DNA molecules. For instance, Illumina Inc.'s September 2022 launch of the NovaSeq X Series introduces a paradigm shift in production-scale sequencing, boasting enhanced speed, power, and sustainability. Leveraging innovative technology such as XLEAP-SBS chemistry and ultra-high density flow cells, the NovaSeq X Series offers substantially increased throughput and sequencing accuracy, meeting the escalating demands for genomic analysis.
In January 2023, QIAGEN NV, a Germany-based provider of molecular testing solutions, acquired Verogen Inc. for $150 million. The acquisition aims to strengthen QIAGEN's molecular testing and forensic genomics offerings by incorporating Verogen's next-generation sequencing (NGS) technology, which enhances capabilities in genetic analysis. Verogen Inc., a US-based company, specializes in NGS solutions focused on human identification (Human ID) and forensic applications.
Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.
North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the clinical next-generation sequencing (NGS) data analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The clinical next-generation sequencing data analysis market consists of revenues earned by entities by providing services such as data preprocessing, alignment, variable calling, annotation, prioritization, interpretation, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical next-generation sequencing data analysis market also includes sales of software tools, platforms, and pre-processing tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on clinical next-generation sequencing (ngs) data analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for clinical next-generation sequencing (ngs) data analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical next-generation sequencing (ngs) data analysis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Solution And Services: NGS Data Analysis Tools; NGS Data Analysis And Sequencing Services; NGS Storage, Management And Cloud Computing Platform; Platforms
- 2) By Technology: Sequencing By Synthesis (SBS); Nanopore Sequencing; Single-Molecule Real-Time (SMRT) Sequencing; Other Technologies
- 3) By Application: Diagnostics; Drug Discovery And Designing; Medical Research; Other Applications
- 4) By End User: Hospitals And Clinics; Academic Institutes And Research Centers; Biotechnology Companies; Life Science Technology Vendors; Other End Users
- Subsegments:
- 1) By NGS Data Analysis Tools: Software Platforms; Data Interpretation Tools; Bioinformatics Tools; Data Analytics Solutions
- 2) By NGS Data Analysis And Sequencing Services: Sequencing Services; Data Analysis Services; Consultation Services; Research And Diagnostic Services
- 3) By NGS Storage, Management, And Cloud Computing Platform: Data Storage Solutions; Data Management Platforms; Cloud-Based Platforms; Cloud Storage Services
- 4) By Platforms: Sequencing Platforms; NGS Instrumentation Platforms; Integrated NGS Platforms
- Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Characteristics
3. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends And Strategies
4. Clinical Next-Generation Sequencing (NGS) Data Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Growth Rate Analysis
- 5.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Total Addressable Market (TAM)
6. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Segmentation
- 6.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- NGS Data Analysis Tools
- NGS Data Analysis And Sequencing Services
- NGS Storage, Management And Cloud Computing Platform
- Platforms
- 6.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencing By Synthesis (SBS)
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Other Technologies
- 6.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostics
- Drug Discovery And Designing
- Medical Research
- Other Applications
- 6.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Academic Institutes And Research Centers
- Biotechnology Companies
- Life Science Technology Vendors
- Other End Users
- 6.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Software Platforms
- Data Interpretation Tools
- Bioinformatics Tools
- Data Analytics Solutions
- 6.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis And Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencing Services
- Data Analysis Services
- Consultation Services
- Research And Diagnostic Services
- 6.7. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Storage, Management, And Cloud Computing Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Data Storage Solutions
- Data Management Platforms
- Cloud-Based Platforms
- Cloud Storage Services
- 6.8. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sequencing Platforms
- NGS Instrumentation Platforms
- Integrated NGS Platforms
7. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Regional And Country Analysis
- 7.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 8.1. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 9.1. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 9.2. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 10.1. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 11.1. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 11.2. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 12.1. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 13.1. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 14.1. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 14.2. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 15.1. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 15.2. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 16.1. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 17.1. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 18.1. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 19.1. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 20.1. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 21.1. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 21.2. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 22.1. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 23.1. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 23.2. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 24.1. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 24.2. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 25.1. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 25.2. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 26.1. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 26.2. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 27.1. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 28.1. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 28.2. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market
- 29.1. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
- 29.2. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape And Company Profiles
- 30.1. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape
- 30.2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Company Profiles
- 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Other Major And Innovative Companies
- 31.1. PerkinElmer Inc.
- 31.2. Bio-Rad Laboratories Inc.
- 31.3. Qiagen
- 31.4. BGI Group
- 31.5. 10x Genomics
- 31.6. Genomic Health
- 31.7. Oxford Nanopore Technologies PLC
- 31.8. Pacific Biosciences of California Inc.
- 31.9. Sophia Genetics
- 31.10. Genewiz
- 31.11. Partek Inc.
- 31.12. DNAnexus
- 31.13. BioNano Genomics
- 31.14. PierianDx
- 31.15. GENAPSYS
32. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market
34. Recent Developments In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market
35. Clinical Next-Generation Sequencing (NGS) Data Analysis Market High Potential Countries, Segments and Strategies
- 35.1 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
